These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33317231)

  • 1. Osteoporosis and Osteoporotic Fracture Fact Sheet in Korea.
    Ahn SH; Park SM; Park SY; Yoo JI; Jung HS; Nho JH; Kim SH; Lee YK; Ha YC; Jang S; Kim TY; Kim HY
    J Bone Metab; 2020 Nov; 27(4):281-290. PubMed ID: 33317231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
    Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
    Bone; 2023 Jan; 166():116605. PubMed ID: 36347433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed initiation of anti-osteoporosis medications increases subsequent hip and vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
    Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
    Bone; 2022 Jul; 160():116396. PubMed ID: 35351673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of subsequent osteoporotic fractures after distal radius fractures and mortality of the subsequent distal radius fractures: a retrospective analysis of claims data of the Korea National Health Insurance Service.
    Jung HS; Jang S; Chung HY; Park SY; Kim HY; Ha YC; Lee YK; Nho JH
    Osteoporos Int; 2021 Feb; 32(2):293-299. PubMed ID: 32876712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
    Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
    Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
    Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H
    Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to Anti-osteoporosis Medication after Hip Fracture in Korean Elderly Patients.
    Yu YM; Lee JY; Lee E
    Maturitas; 2017 Sep; 103():54-59. PubMed ID: 28778333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture in Taiwan.
    Wang CY; Fu SH; Hung CC; Yang RS; Lin JW; Chen HM; Hsiao FY; Shen LJ
    Int J Health Policy Manag; 2022 Apr; 11(4):470-478. PubMed ID: 33059424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data.
    Kang HY; Yang KH; Kim YN; Moon SH; Choi WJ; Kang DR; Park SE
    BMC Public Health; 2010 May; 10():230. PubMed ID: 20438644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and outcome of osteoporotic fractures in 2004 in Sado City, Niigata Prefecture, Japan.
    Sakuma M; Endo N; Oinuma T; Endo E; Yazawa T; Watanabe K; Watanabe S
    J Bone Miner Metab; 2008; 26(4):373-8. PubMed ID: 18600404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and mortality of subsequent vertebral fractures: analysis of claims data of the Korea National Health Insurance Service from 2007 to 2016.
    Park SM; Ahn SH; Kim HY; Jang S; Ha YC; Lee YK; Chung HY
    Spine J; 2020 Feb; 20(2):225-233. PubMed ID: 31589928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: A nationwide cohort study.
    Wang CY; Fu SH; Yang RS; Chen LK; Shen LJ; Hsiao FY
    Bone; 2020 Sep; 138():115452. PubMed ID: 32464276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of osteoporosis treatment to reduce the risk of subsequent osteoporotic fracture and all-cause mortality in elderly hip fracture patients in a Korean real-world study.
    Lee SJ; Cho M; Lee H; Lim H; Lee JH
    Arch Osteoporos; 2024 Jan; 19(1):9. PubMed ID: 38198067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National utilization of calcium supplements in patients with osteoporotic hip fracture in Korea.
    Kim SH; Ko YB; Lee YK; Hong SW; Choi HJ; Ha YC; Shin CS
    J Bone Metab; 2013 Nov; 20(2):99-103. PubMed ID: 24524065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data.
    Kim JW; Jeon YJ; Baek DH; Kim TN; Chang JS
    Osteoporos Int; 2014 Apr; 25(4):1313-9. PubMed ID: 24345885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.
    Skjødt MK; Ernst MT; Khalid S; Libanati C; Cooper C; Delmestri A; Rubin KH; Javaid MK; Martinez-Laguna D; Toth E; Prieto-Alhambra D; Abrahamsen B
    Osteoporos Int; 2021 Oct; 32(10):1961-1971. PubMed ID: 33721032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Osteoporosis & Osteoporotic Fractures in Korea Based on Health Insurance Review and Assessment (HIRA) Database: 2009-2017.
    Oh HS; Kim SK; Seo HY
    Healthcare (Basel); 2021 Mar; 9(3):. PubMed ID: 33799330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Persistence and Medication Switch Associated With Subsequent Fractures After Osteoporotic Fractures.
    Lin SY; Chen WJ; Ku CK; Chen YM; Chen CH; Chien LN
    J Clin Endocrinol Metab; 2023 Dec; 109(1):e200-e208. PubMed ID: 37526298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population.
    Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1178-1190. PubMed ID: 29083977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.